Merck's experimental eye drug meets goal in trial, but raises safety concerns

Roche's experimental eye drug shows vision improvements in trials

The S&P 500 Just Hit a Record High -- Here's How Much Higher It Can Climb, According to the Wall Street Consensus

Global equities mixed amid rising yields and oil prices

Marko Kolanovic calls Trump’s energy ceasefire a ‘con,’ Tom Lee sees potential inflation relief